FOGSI EEBR 2025: Ethical Evidence-Based Recommendations: Fibroids
-
- Englisch ausgewählt
35,99 €
inkl. gesetzl. MwSt.,
Lieferung nach Hause
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
26.11.2024
Verlag
Jaypee Brothers Medical PublishersSeitenzahl
154
Maße (L/B/H)
24/16,2/0,8 cm
Gewicht
234 g
Sprache
Englisch
ISBN
978-93-6616-245-4
Written in association with the Federation of Obstetric and Gynaecological Societies of India (FOGSI), and with contributions from a multitude of recognised experts led by FOGSI (2025-2026) president Sunita Tandulwadkar; the Ethical Evidence-based Recommendations (EEBR) series provides clinicians with the latest updates and advances in the field, with each book focusing on a different subspecialty.
Uterine fibroids are growths made of muscle and tissue that form in or on the wall of the uterus. They are usually benign and are the most common noncancerous tumour in females. Fibroids can cause a variety of symptoms including pain and heavy irregular bleeding. Some women have no symptoms and are unaware that they have the condition.
The EEBRs in this book begin with detail on the origins, aetiology, pathophysiology, and risk factors associated with fibroids, providing practitioners with a fundamental understanding of hormonal, genetic and environmental influences. The text examines clinical presentation and locations of fibroids, atypical fibroids, and degeneration patterns, helping clinicians recognise and manage the diversities of the condition effectively.
Other titles in the series include:
- Antenatal Fetal Surveillance
- Endometriosis
- Genetics in Obstetrics and Gynecology
- Hyperglycemia in Pregnancy
- Hypertensive Disorders of Pregnancy
- Induction of Labor
- Polycystic Ovary Syndrome
- Postpartum Hemorrhage
- Preterm Labor
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung
Kurze Frage zu unserer Seite
Vielen Dank für dein Feedback
Wir nutzen dein Feedback, um unsere Produktseiten zu verbessern. Bitte habe Verständnis, dass wir dir keine Rückmeldung geben können. Falls du Kontakt mit uns aufnehmen möchtest, kannst du dich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice